EDITORIAL
Published on 23 Dec 2024
Editorial: Model Organisms in Respiratory Pharmacology
doi 10.3389/fphar.2024.1540222
- Frontiers in Pharmacology
- Respiratory Pharmacology
- Research Topics
- Model Organisms in Respiratory Pharmacology 2023
Model Organisms in Respiratory Pharmacology 2023
2,530
Total Downloads
7,893
Total Views and Downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 25 Sep 2024
Airspaces-derived exosomes contain disease-relevant protein signatures in a mouse model of cystic fibrosis (CF)-like mucoinflammatory lung disease
doi 10.3389/fphar.2024.1460692
- 594 views
ORIGINAL RESEARCH
Published on 13 Mar 2024
Effect of elexacaftor-tezacaftor-ivacaftor on nasal potential difference and lung function in Phe508del rats
doi 10.3389/fphar.2024.1362325
- 988 views
- 4 citations
ORIGINAL RESEARCH
Published on 23 Nov 2023
A novel approach to pulmonary bronchial tree model construction and performance index study
doi 10.3389/fphar.2023.1254804
- 1,094 views
ORIGINAL RESEARCH
Published on 24 Aug 2023
Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx
doi 10.3389/fphar.2023.1236469
- 1,590 views
- 2 citations
ORIGINAL RESEARCH
Published on 22 May 2023
STC3141 improves acute lung injury through neutralizing circulating histone in rat with experimentally-induced acute respiratory distress syndrome
doi 10.3389/fphar.2023.1166814
- 1,538 views
- 6 citations
Published in
Frontiers in Pharmacology
- Respiratory Pharmacology
Impact
- 7,893Topic views
- 4,666Article views
- 2,530Article downloads